Uveitis Therapeutics Market Size in the 7MM was ~USD 1,468.66 million in 2022 and It is expected to grow at a significant CAGR by 2034, estimates DelveInsight

Uveitis Therapeutics Market Size in the 7MM was ~USD 1,468.66 million in 2022 and It is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Uveitis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of uveitis, historical and forecasted epidemiology, as well as the uveitis market trends in the

Read More

Dermatomyositis Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Dermatomyositis Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dermatomyositis pipeline landscape. It covers the Dermatomyositis pipeline drug profiles, including clinical and

Read More

Schizophrenia Pipeline Accelerates as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Schizophrenia Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Schizophrenia pipeline landscape. It covers the Schizophrenia Pipeline drug profiles, including clinical

Read More

Gorlin Syndrome Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome pipeline landscape. It covers the Gorlin Syndrome pipeline drug profiles,

Read More

Parkinson Disease Clinical Trial Pipeline Gains Momentum: 150+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Parkinson’s Disease Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs in Parkinson’s Disease pipeline landscape. It covers the Parkinson’s Disease pipeline drug profiles,

Read More

Renal Cell Carcinoma Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Renal Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Renal Cell Carcinoma pipeline landscape. It covers the Renal Cell

Read More

Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Expands as 70+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Idiopathic Pulmonary Fibrosis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary

Read More

Graft versus Host Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight

elveInsight’s, “Graft versus host disease Pipeline Insight 2026” report provides comprehensive insights about 45+ Graft Versus Host Disease Companies and 50+ pipeline drugs in Graft versus host disease pipeline landscape.

Read More

Hanley Investment Group Chief Operations Officer Tiffanie Farr Named to GlobeSt. 2026 Women of Influence

CORONA DEL MAR, Calif. — Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that Tiffanie Farr,

Read More

Automotive Collision Repair Market to Reach USD 267.86 Billion by 2035, Rising Vehicle Ownership, Insurance Claim Growth, and Advanced Repair Technology Adoption

Automotive Collision Repair Market Outlook 2026 to 2035 “Automotive Collision Repair Market Size, Share & Growth Analysis Report — Industry Trends & Forecast to 2035” (Report ID: MRFR/AT/20547-HCR, 128 pages)

Read More